XABIER
CAMINO ORTIZ DE BARRÓN
![Foto de XABIER](/img/nophoto.png)
![Foto de Centro Nacional de Epidemiología](/img/noimage_org.png)
Centro Nacional de Epidemiología
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Epidemiología (20)
2022
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Implementation of pre-exposure prophylaxis programme in Spain. Feasibility of four different delivery models
PLoS ONE, Vol. 16, Núm. 2 February
2020
2018
-
Impact of co-infection by hepatitis C virus on immunological and virological response to antiretroviral therapy in HIV-positive patients
Medicine (United States), Vol. 97, Núm. 38
-
Low-level viremia is associated with clinical progression in HIV-infected patients receiving antiretroviral treatment
Journal of Acquired Immune Deficiency Syndromes, Vol. 78, Núm. 3, pp. 329-337
-
Role of HIV in the desire of procreation and motherhood in women living with HIV in Spain: A qualitative approach
BMC Women's Health, Vol. 18, Núm. 1
2016
-
Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013
Journal of Infection, Vol. 72, Núm. 5, pp. 587-596
-
Incidence and clearance of anal high-risk human papillomavirus in HIV-positive men who have sex with men: Estimates and risk factors
AIDS, Vol. 30, Núm. 1, pp. 37-44
2015
-
Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5
-
Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)
Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5
2014
-
Incidence of Hepatitis C Virus (HCV) in a multicenter cohort of HIV-positive patients in Spain 2004-2011: Increasing rates of HCV diagnosis but not of HCV seroconversions
PLoS ONE, Vol. 9, Núm. 12
-
Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries
AIDS, Vol. 28, Núm. 16, pp. 2461-2473
-
Tuberculosis in a cohort of HIV-positive patients: Epidemiology, clinical practice and treatment outcomes
International Journal of Tuberculosis and Lung Disease, Vol. 18, Núm. 6
2009
-
Delayed diagnosis of HIV infection in a multicenter cohort: Prevalence, risk factors, response to HAART and impact of mortality
Current HIV Research, Vol. 7, Núm. 2, pp. 224-230
-
Eligibility for and outcome of treatment of latent tuberculosis infection in a cohort of HIV-infected people in Spain
BMC Infectious Diseases, Vol. 10
-
Infección por virus de la inmunodeficiencia humana en inmigrantes en España: características epidemiológicas y presentación clínica en la cohorte CoRIS, 2004-2006
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 27, Núm. 7, pp. 380-388
2008
-
Incidence and risk factors for tuberculosis in HIV-positive subjects by HAART status
International Journal of Tuberculosis and Lung Disease, Vol. 12, Núm. 12, pp. 1393-1400
-
Patients' characteristics and clinical implications of suboptimal CD4 T-cell gains after 1 year of successful antiretroviral therapy
Current HIV Research, Vol. 6, Núm. 2, pp. 100-107
2007
-
Riesgo elevado de infección por el virus de la inmunodeficiencia humana en varones homosexuales incluso después del contacto con el sistema sanitario
Enfermeria Clinica, Vol. 17, Núm. 6, pp. 302-308